ISMO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ismo, and what generic alternatives are available?
Ismo is a drug marketed by Promius Pharma and Alcon and is included in two NDAs.
The generic ingredient in ISMO is isosorbide. There are thirty-seven drug master file entries for this compound. Additional details are available on the isosorbide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISMO?
- What are the global sales for ISMO?
- What is Average Wholesale Price for ISMO?
Summary for ISMO
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Patent Applications: | 4,076 |
| DailyMed Link: | ISMO at DailyMed |
US Patents and Regulatory Information for ISMO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promius Pharma | ISMO | isosorbide mononitrate | TABLET;ORAL | 019091-001 | Dec 30, 1991 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Alcon | ISMOTIC | isosorbide | SOLUTION;ORAL | 017063-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
